Han Bing Shang

470 total citations
9 papers, 381 citations indexed

About

Han Bing Shang is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Han Bing Shang has authored 9 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Genetics. Recurrent topics in Han Bing Shang's work include Pituitary Gland Disorders and Treatments (4 papers), Glioma Diagnosis and Treatment (2 papers) and Cancer-related molecular mechanisms research (2 papers). Han Bing Shang is often cited by papers focused on Pituitary Gland Disorders and Treatments (4 papers), Glioma Diagnosis and Treatment (2 papers) and Cancer-related molecular mechanisms research (2 papers). Han Bing Shang collaborates with scholars based in China, United States and Thailand. Han Bing Shang's co-authors include Zhe Wu, Lin Cai, Ze Wu, Wei Zhao, Yu Guo, Hao Tang, Shao Jian Lin, Yong Wei, Hong Yao and Wei-Dong Le and has published in prestigious journals such as Nature Communications, The Journal of Clinical Endocrinology & Metabolism and Cancer Letters.

In The Last Decade

Han Bing Shang

8 papers receiving 381 citations

Peers

Han Bing Shang

MB

CR

EDM

EPIDE

GENET

Ze Wu China

Shao Jian Lin China

Sandy Hsu United States

Mariana Fuertes Argentina

Jacek Kunicki Poland

Elena Giardino Italy

Donatella Treppiedi Italy

Stefanie V. Schütz Germany

Yue-Hui Ma China

Zsófia Tömböl Hungary

Ze Wu China

Han Bing Shang

214 ×1.0

MB

152 ×0.8

CR

80 ×0.7

EDM

60 ×0.8

EPIDE

35 ×0.7

GENET

Citations per year, relative to Han Bing Shang Han Bing Shang (= 1×) peers Ze Wu

Countries citing papers authored by Han Bing Shang

Since Specialization

Citations

This map shows the geographic impact of Han Bing Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Bing Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Bing Shang more than expected).

Fields of papers citing papers by Han Bing Shang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Bing Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Bing Shang. The network helps show where Han Bing Shang may publish in the future.

Co-authorship network of co-authors of Han Bing Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Han Bing Shang. A scholar is included among the top collaborators of Han Bing Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Bing Shang. Han Bing Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Tang, Haotian, et al.. (2022). [Clinical observation of microsurgical removal of the hemilateral tuberculum sellae meningiomas through contralateral eyebrow arch approach].. PubMed. 102(33). 2630–2633.

2.

Yao, Hong, Hao Tang, Yong Zhang, et al.. (2019). DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma. Cancer Letters. 459. 135–144. 18 indexed citations

3.

Zhang, Yong, Hao Tang, Hong Yao, et al.. (2019). Exosome-Transmitted lncRNA H19 Inhibits the Growth of Pituitary Adenoma. The Journal of Clinical Endocrinology & Metabolism. 104(12). 6345–6356. 54 indexed citations

4.

Wu, Ze, Lichong Yan, Lei Cao, et al.. (2018). Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours. Nature Communications. 9(1). 4624–4624. 111 indexed citations

5.

Lin, Shao Jian, Ze Wu, Yu Guo, et al.. (2017). Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death. Autophagy. 13(8). 1404–1419. 81 indexed citations

6.

Lin, Shao Jian, Ze Wu, Lei Cao, et al.. (2017). Pituitary Tumor Suppression by Combination of Cabergoline and Chloroquine. The Journal of Clinical Endocrinology & Metabolism. 102(10). 3692–3703. 30 indexed citations

7.

Wu, Ze, Yong Zhang, Lin Cai, et al.. (2016). Long-Term Clinical Outcomes of Invasive Giant Prolactinomas after a Mean Ten-Year Followup. International Journal of Endocrinology. 2016. 1–7. 10 indexed citations

8.

Lin, Shao Jian, Yu Guo, Lin Cai, et al.. (2015). Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline. Oncotarget. 6(36). 39329–39341. 37 indexed citations

9.

Wu, Zhe, Shao Jian Lin, Lin Cai, et al.. (2014). MicroRNA expression profile of bromocriptine-resistant prolactinomas. Molecular and Cellular Endocrinology. 395(1-2). 10–18. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact